Literature DB >> 27473799

Patient Selection and Surgical Management of High-Risk Patients with Morbid Obesity.

A Daniel Guerron1, Dana D Portenier2.   

Abstract

Bariatric surgery is the most effective way to improve comorbidities related to obesity. Since the introduction of minimally invasive laparoscopic surgery in the bariatric surgery techniques, the number of procedures has increased substantially; advances in techniques and the transition from open to minimally invasive procedures have decreased morbidity and mortality. Multidisciplinary teams in charge of the operative planning, surgical act, and postoperative recovery are determinant in the success of the management of high-risk bariatric patients; careful identification and preoperative management of these higher-risk patients is crucial in decreasing complications after weight loss surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  End organ failure; High risk; Risk factors

Mesh:

Year:  2016        PMID: 27473799     DOI: 10.1016/j.suc.2016.03.009

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Concurrent bariatric operations and association with perioperative outcomes: registry based cohort study.

Authors:  Jason B Liu; Kristen A Ban; Julia R Berian; Matthew M Hutter; Kristopher M Huffman; Yaoming Liu; David B Hoyt; Bruce L Hall; Clifford Y Ko
Journal:  BMJ       Date:  2017-09-26

2.  The evaluation of risk prediction models in predicting outcomes after bariatric surgery: a prospective observational cohort pilot study.

Authors:  David Andrew Gilhooly; Michelle Cole; Suneetha Ramani Moonesinghe
Journal:  Perioper Med (Lond)       Date:  2018-04-10

3.  Changes in DNA Methylation and Gene Expression of Insulin and Obesity-Related Gene PIK3R1 after Roux-en-Y Gastric Bypass.

Authors:  Marcela A S Pinhel; Natália Y Noronha; Carolina F Nicoletti; Vanessa Ab Pereira; Bruno Ap de Oliveira; Cristiana Cortes-Oliveira; Wilson Salgado; Fernando Barbosa; Júlio S Marchini; Doroteia Rs Souza; Carla B Nonino
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.